The Nutshell

» disease/medicine and cell & molecular biology

Daily News Roundup

Most Recent

image: Prominent Cell Biologist Dies

Prominent Cell Biologist Dies

By | May 4, 2015

Cytoskeleton specialist Alan Hall was best known for unpacking the roles of Rho GTPases.   


image: Outsmarting HIV

Outsmarting HIV

By | May 4, 2015

Small molecules that mimic the T-cell surface receptor CD4 could expose the virus to antibody-based immune responses.


image: FDA Calls for Data on ALS Drug

FDA Calls for Data on ALS Drug

By | April 21, 2015

In the midst of a debate about an experimental drug’s early approval, the US Food and Drug Administration requests that full trial results be released.

1 Comment

image: Protein Spurs T-Cell Proliferation

Protein Spurs T-Cell Proliferation

By | April 17, 2015

A newly discovered protein promotes immunity to viruses and cancer by triggering the production of cytotoxic T cells.

1 Comment

image: Cannabidiol Quells Seizures

Cannabidiol Quells Seizures

By | April 14, 2015

The marijuana-derived compound shows promise in treating rare forms of epilepsy that cause children to have seizures multiple times a day.


image: Why DBS Works for Parkinson’s?

Why DBS Works for Parkinson’s?

By | April 14, 2015

Deep-brain stimulation may effectively treat slow movement, tremor, and rigidity in Parkinson’s patients by reducing synchronicity of neural activity in the motor cortex.


image: Cellular Garbage Disposal Illuminated

Cellular Garbage Disposal Illuminated

By | April 13, 2015

A Harvard team shows how cells label and recognize proteins for degradation.


image: Ebola Vaccines Protect Monkeys

Ebola Vaccines Protect Monkeys

By | April 9, 2015

Two new Ebola vaccine candidates prove safe and effective against the virus in macaques, a study shows.


image: HIV Antibody Therapy

HIV Antibody Therapy

By | April 8, 2015

Delivering antibodies to HIV-infected people can lower levels of the virus, a study shows.


image: ALS Drug Access Debated

ALS Drug Access Debated

By | April 7, 2015

Biotech company Genervon has requested accelerated approval for its experimental ALS drug after a small but promising Phase 2 trial. Patients advocate for its acceptance, while researchers urge caution.


Popular Now

  1. Inside a Lab Mouse’s High-Fat Diet
  2. Battling the Bulge
    Bio Business Battling the Bulge

    Weight-loss drugs that target newly characterized obesity-related receptors and pathways could finally offer truly effective fat control.

  3. How Gastric Bypass Can Kill Sugar Cravings
  4. Birth of the Skin Microbiome
    Daily News Birth of the Skin Microbiome

    The immune system tolerates the colonization of commensal bacteria on the skin with the aid of regulatory T cells during the first few weeks of life, a mouse study shows.

Life Technologies